Exploring how certain compounds can enhance oxygen reactions for drug development
Understanding How Thiolates Promote Dioxygen Chemistry
This study is looking at how certain special compounds can help create better antibiotics to fight stubborn infections and new drugs to stop cancer from spreading, which could lead to more effective treatments for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11052539 on NIH RePORTER |
What this research studies
This research investigates the role of cysteine-ligated non-heme iron superoxo intermediates in the mechanisms of antibiotic and anticancer drug synthesis. By understanding how these compounds interact with oxygen, the research aims to develop new antibiotics that can combat resistant bacteria and new drugs that may prevent cancer metastasis. The approach involves manipulating the chemical structure of these compounds to observe changes in their reactivity and effectiveness. Patients may benefit from the potential development of more effective treatments for bacterial infections and cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients suffering from bacterial infections that are resistant to current antibiotics or those with cancer at risk of metastasis.
Not a fit: Patients with non-bacterial infections or those not affected by cancer may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the creation of new antibiotics and anticancer drugs that are more effective against resistant strains and metastatic cancer.
How similar studies have performed: Other research has shown promise in similar approaches, particularly in the development of new antibiotics and cancer therapies, indicating a potential for success in this area.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Kovacs, Julia a — University of Washington
- Study coordinator: Kovacs, Julia a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.